Braveheart Investment Group PLC (LON:BRH) has provided an update on the progress with proof of concept for a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.
The investment group said the proof of concept trials are focused on two separate elements of the test, the Optical Detection System, and Capture & Signal Generation Modules, both of which are required to be achieved for the trial to be successful.
READ: Braveheart Investment Group updates on progress of investee firm Phasefocus Holdings
Proof of concept has been achieved for the Optical Detection System and development work continues to optimise detection sensitivity, the AIM-listed firm said in a statement.
Minor logistical issues arising from increased regional COVID-19 restrictions has meant that final proof of concept trials continue for the Capture & Signal Generation Modules and the results are now anticipated on October 16, it added.
Shares advanced 5% to 34p on Monday at noon.